A young adult comes to the clinic complaining of significant ear pain and is diagnosed with otitis externa (OE) with an intact tympanic membrane. The NP should prescribe:

Serotonin syndrome is a potentially life-threatening condition caused by excessive serotonergic activity in the central nervous system. It commonly occurs when selective serotonin reuptake inhibitors (SSRIs) are combined with other serotonergic drugs, given in excessive doses, or switched inappropriately without adequate washout periods. Symptoms may include agitation, hyperthermia, tremors, diarrhea, tachycardia, and neuromuscular hyperactivity. Prevention is primarily based on safe prescribing practices and careful medication review.

Rationale:
A. Avoiding doses above the maximum recommended limit is essential because excessive serotonin levels can result from overdosing or overly aggressive dose escalation of SSRIs. Higher doses increase serotonergic neurotransmission and raise the risk of toxicity, especially in sensitive patients. Prescribers must follow evidence-based dosing guidelines and monitor for early warning signs of serotonin excess during therapy adjustments.

B. Avoiding other medications with serotonergic properties is a major preventive strategy because drug interactions are one of the most common causes of serotonin syndrome. Medications such as MAO inhibitors, triptans, tramadol, linezolid, and even some herbal supplements like St. John’s wort can significantly increase serotonin levels. Combining these agents with SSRIs can rapidly precipitate dangerous symptoms.

C. Allowing adequate time for titration and washout when switching antidepressants is critical because residual serotonergic effects may persist even after stopping one medication. Drugs such as Fluoxetine have long half-lives and require extra caution before starting another serotonergic agent. Gradual transitions reduce overlapping serotonin activity and help prevent toxicity.

D. All options are correct because serotonin syndrome prevention requires attention to dosage, drug interactions, and safe transitions between medications. No single intervention is sufficient on its own since the syndrome often results from multiple contributing factors. Comprehensive prescribing practices and patient education together provide the safest approach to minimizing the risk of this serious adverse reaction.

Recurrent urinary tract infections (UTIs) with systemic symptoms suggest a more complicated infection, possibly involving upper urinary tract involvement such as pyelonephritis or resistant organisms. Treatment selection must consider local antimicrobial resistance patterns, severity of symptoms, and prior antibiotic exposure. Broader-spectrum antibiotics are often required when resistance is a concern or when infection is not limited to the lower urinary tract. Therapy duration is also extended in more complex presentations.

Rationale:
A. Ciprofloxacin (Cipro) is an appropriate option in this scenario because it provides broad-spectrum coverage against common urinary pathogens and achieves good tissue penetration, including renal tissue. In a patient with recurrent UTI and systemic symptoms, there is concern for resistant organisms or upper tract involvement, making fluoroquinolones a reasonable choice when resistance patterns support their use. A 7-day course is consistent with treatment for complicated infection.

B. Trimethoprim-sulfamethoxazole (Bactrim) is typically used for uncomplicated cystitis with a short 3-day course when local resistance rates are low. However, in recurrent infections with systemic symptoms and concern for resistance, it may be ineffective due to increasing E. coliresistance. It is not the best empiric choice in this higher-risk presentation.

C. Clarithromycin (Biaxin) is not appropriate for urinary tract infections because it has poor activity against common uropathogens such as E. coli. Macrolides are primarily used for respiratory and certain atypical infections, not urinary tract infections. Therefore, it would not provide adequate empiric coverage in this case.

D. Fosfomycin (Monurol) is used as a single-dose therapy for uncomplicated lower urinary tract infections. It is not appropriate for recurrent UTIs with systemic symptoms or suspected upper urinary tract involvement. Its limited systemic penetration makes it unsuitable for more complicated or resistant infections.